Renal transplantation: Progress and prospects

Artificial Organs

Volumn 20, Issue 6, 1996, Pages 403-407

  Hillebrand, Günther F ^a,b   Land, Walter ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

graft prognosis; kidney transplantation; multimorbidity; new immunosuppressants; patient population

Indexed keywords

DIAGNOSIS; GRAFTING (CHEMICAL); GRAFTS;

DIABETES MELLITUS; GRAFT PROGNOSE; IMMUNOSUPPRESSANTS; KIDNEY TRANSPLANTATION; MULTIMORBIDITY; NEW IMMUNOSUPPRESSANT; PATIENT POPULATION; RENAL TRANSPLANTATION; RISK FACTORS; WAITING LISTS;

DIALYSIS;

AZATHIOPRINE; CYCLOSPORIN A; MONOCLONAL ANTIBODY; STEROID;

CONFERENCE PAPER; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MORBIDITY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029977246     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04523.x     Document Type: Conference Paper

References (18)

1. Ceppellini R. The basic genetics of transplantation. In: Rapaport FT, Dausset J, eds. Human transplantation. New York/London: Grune & Stratton, 1968;3:21-33.
2. Opelz G. Collaborative transplant study: 10-year report. Transplant Proc 1992;6:2342-55.
3. Terasaki PI, ed. Clinical transplants. Los Angeles: University of California, Los Angeles, Tissue Typing Laboratory, 1995:12-5.
4. Petersen P, Schneeberger H, Schleibner S, Illner WD, Hofmann GO, Scholz S, Albert ED, Land W. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses. Transplant Proc 1995;1:651-2.
5. Cohen B, Persijn G, De Meester J. Eurotransplant Foundation Annual Report 1994. Leiden: Eurotransplant Foundation, 1994:38.
6. Valderrabano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995;10(Suppl 5):1-25.
7. Schneeberger H, Schleibner S, Illner WD, Abendroth D, Hofmann G, Hillebrand G, Theodorakis J, Land W. Kidney transplantation in the cyclosporine era - the Munich experience. Transplant Proc 1992;4(Suppl 2):78-81.
8. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995;3:313-8.
9. Paul LC. Chronic renal transplant loss. Kidney Int 1995;47: 1491-9.
10. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 4:752-7.
11. Albrechtsen D, Leivestad T, Sodal G, Bentdal O, Berg KJ, Brekke I, Fauchald P, Flatmark A, Jacobsen A, Lien B, Nordal K, Pfeffer P, Thorsby E, Soreide O. Kidney transplantation in patients older than 70 years of age. Transplant Proc 1995;1:986-8.
12. Suthanhiran M, Strom TB. Renal transplantation. N Engl J Med 1994;6:365-76.
13. Luke RG. New issues in therapy after renal transplantation. N Engl J Med 1994;6:394-5.
14. Calne R. Impact of immunosuppressants on host tissue and tolerance. Transplantation Proc 1994;5:3065-70.
15. Land W. The problem of living organ donation: facts, thoughts, and reflections. Transpl Int 1989;2:168-79.
16. Terasaki PI, Cecka M, Gjertson DW, Takemoto S. High survival rate of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995;6:333-6.
17. Soulillou JP. Kidney transplantation from spousal donors. N Engl J Med 1995;6:379-80.
18. Veatch RM. Theories of medical ethics: the professional model compared with the societal model. In: Land W, Dossetor JB, eds. Organ replacement therapy: ethics, justice, commerce. Berlin/Heidelberg: Springer, 1991:3-9.